Revelation Biosciences Warrant

REVBW

Market cap $8.74K

REVBW Hedge Fund Activity: Q1 2026 in Review

11 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2026, worth a combined $6.66K — down 35% from $10.2K a quarter earlier.

Fund positioning in REVBW was balanced in Q1 2026: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $5. The largest seller was POM Investment Strategies, exiting entirely with an estimated $8 sold.

• 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2026, unchanged from Q4 2025.
• Funds reported $6.66K of Revelation Biosciences Warrant stock for Q1 2026, down 35% quarter-over-quarter.
• 1 fund opened new Revelation Biosciences Warrant positions in Q1 2026 and 1 closed out, a net change of 0 holders.
• The largest Revelation Biosciences Warrant buyer in Q1 2026 was UBS Group, an estimated $5 added.
• The largest Revelation Biosciences Warrant seller in Q1 2026 was POM Investment Strategies, an estimated $8 sold.

Based on aggregated 13F filings for Q1 2026.